These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15375537)

  • 21. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
    Persons DL; Hartmann LC; Herath JF; Borell TJ; Cliby WA; Keeney GL; Jenkins RB
    Am J Pathol; 1993 Mar; 142(3):733-41. PubMed ID: 8096121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
    Sokolova IA; Halling KC; Jenkins RB; Burkhardt HM; Meyer RG; Seelig SA; King W
    J Mol Diagn; 2000 Aug; 2(3):116-23. PubMed ID: 11229514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of 20q13 gain by dual-color FISH in breast cancers.
    Kobayashi Y; Esato K; Noshima S; Oga A; Sasaki K
    Anticancer Res; 2000; 20(1B):531-5. PubMed ID: 10769720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multitarget fluorescence in situ hybridization and melanoma antigen genes analysis in primary bladder carcinoma.
    Kang JU; Koo SH; Jeong TE; Kwon KC; Park JW; Jeon CH
    Cancer Genet Cytogenet; 2006 Jan; 164(1):32-8. PubMed ID: 16364760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients.
    Panani AD; Babanaraki A; Malianga E; Roussos Ch
    Anticancer Res; 2004; 24(6):3857-61. PubMed ID: 15736422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
    Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
    BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].
    Giedl J; Wild PJ; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
    Verh Dtsch Ges Pathol; 2006; 90():253-63. PubMed ID: 17867604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 11q23-24 loss is associated with chromosomal instability in endometrial cancer.
    Kawasaki K; Suehiro Y; Umayahara K; Morioka H; Ito T; Saito T; Tsukamoto N; Sugino N; Kato H; Sasaki K
    Int J Mol Med; 2003 Nov; 12(5):727-31. PubMed ID: 14533001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New WHO classification of urothelial carcinoma of the urinary bladder].
    Helpap B
    Verh Dtsch Ges Pathol; 2002; 86():57-66. PubMed ID: 12647352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
    Panani AD; Roussos C
    Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality.
    Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R
    Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Numerical aberrations of chromosomes 8, 9, 11, and 17 in squamous cell carcinoma of the pharynx and larynx: a fluorescence in situ hybridization and DNA flow cytometric analysis of 50 cases.
    Hardisson D; Alvarez-Marcos C; Salas-Bustamante A; Alonso-Guervós M; Sastre N; Sampedro A
    Oral Oncol; 2004 Apr; 40(4):409-17. PubMed ID: 14969820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma - FISHing for the right catch.
    Bubendorf L
    Acta Cytol; 2011; 55(2):113-9. PubMed ID: 21325794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium.
    Steidl C; Simon R; Bürger H; Brinkschmidt C; Hertle L; Böcker W; Terpe HJ
    J Pathol; 2002 Sep; 198(1):115-20. PubMed ID: 12210071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is aneusomy of chromosome 9 alone a valid biomarker for urinary bladder cancer screening?
    Panani AD; Kozirakis D; Anastasiou J; Babanaraki A; Malovrouvas D; Roussos C
    Anticancer Res; 2006; 26(2A):1161-5. PubMed ID: 16619518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of the decision tree technique and image cytometry to characterize aggressiveness in World Health Organization (WHO) grade II superficial transitional cell carcinomas of the bladder.
    Decaestecker C; van Velthoven R; Petein M; Janssen T; Salmon I; Pasteels JL; van Ham P; Schulman C; Kiss R
    J Pathol; 1996 Mar; 178(3):274-83. PubMed ID: 8778332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.
    Castro P; Eknaes M; Teixeira MR; Danielsen HE; Soares P; Lothe RA; Sobrinho-Simões M
    J Pathol; 2005 Jul; 206(3):305-11. PubMed ID: 15852498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder.
    Morton MJ; Zhang S; Lopez-Beltran A; MacLennan GT; Eble JN; Montironi R; Sung MT; Tan PH; Zheng S; Zhou H; Cheng L
    Clin Cancer Res; 2007 Oct; 13(20):6232-6. PubMed ID: 17947491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.